Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Three RDM researchers have been awarded the title of Full Professor in the University’s 2025 Recognition of Distinction exercise.

Bethan Psaila, James Davies, Rajesh Kharbanda

Congratulations to:

Beth Psaila, Professor of Haematology

Beth's research group focuses on megakaryocyte and platelet biology and the role of the tumour microenvironment in blood cancers. Beth was awarded a Senior Fellowship by Cancer Research UK in partnership with Rosetrees Trust and appointed as an Associate Member of the Ludwig Institute for Cancer Research last year to continue her efforts in understanding what drives some cancers to progress from indolent to advanced-stage disease, and how to translate new discoveries to new therapies.

James Davies, Professor of Genomics

James is a clinician scientist with interests in genomics, bioinformatics, genome editing, and advanced cell therapies. His research group is based in the MRC Molecular Haematology Unit at the Weatherall Institute of Molecular Medicine. James' research focuses on developing new technologies to delineate how DNA is structured within cells and to understand how genetic variation leads to disease. He also has a strong interest in using genome editing both to investigate how alterations in DNA sequence cause disease and to engineer haemopoietic stem cells for use in clinical bone marrow transplantation.

Rajesh Kharbanda, Professor of Cardiovascular Medicine

Rajesh studied medicine at Edinburgh Medical School. He trained in cardiology in London, Cambridge and Toronto. He obtained PhD from University College London and was Clinical Lecturer at the University of Cambridge, before moving to Oxford in 2007 to join the Division of Cardiovascular Medicine. He is a clinical academic and works as a clinician in Oxford University Hospitals NHS Foundation Trust and across RDM's Division of Cardiovascular Medicine and the Oxford Biomedical Research Centre.

His research focus is to improve the outcomes from valve and coronary disease. A recent focus has been understanding outcomes using large cohorts and from randomised trials. As therapies for valve disease expand, he is researching the longer-term outcomes, investigating patient reported outcomes and the value to healthcare.

Applying for Professor

The University's Recognition of Distinction Scheme is an annual exercise to confer the title of full professor. All those employed by the University in academic or senior research roles are eligible to apply, as are other University employees who are making a significant and sustained academic contribution to the University, across three criteria; research, teaching and citizenship. More information about the application procedure can be found on the University website.

 

Similar stories

New technology helps decode the genetic changes behind disease

RDM researchers have developed a new technology that can reveal new therapeutic targets from common genetic variants linked to disease.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Professor Marella de Bruijn receives MRC Programme Award

Congratulation to Professor de Bruijn, who has been awarded funding from the UKRI Medical Research Council to investigate how the first blood stem cells formed in the embryo acquire their exceptional regenerative potential, with the aim of informing future stem cell therapies.

How body fat is stored across organs may reveal hidden health risks, study suggests

University of Oxford researchers have found that how fat accumulates in the body is just as important for identifying different health risks as a person’s overall weight.

Professor KJ Patel awarded Royal Society Buchanan Medal

Congratulations to Professor Patel, who has received the Buchanan Medal, which recognises distinguished contributions to the biomedical sciences.

New pump-priming awards support cross-cutting research across RDM

Five Radcliffe Department of Medicine research teams have secured pump-priming funding to support new collaborations and early-stage research aligned with RDM’s cross-cutting research themes.

Similar stories

New technology helps decode the genetic changes behind disease

RDM researchers have developed a new technology that can reveal new therapeutic targets from common genetic variants linked to disease.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Professor Marella de Bruijn receives MRC Programme Award

Congratulation to Professor de Bruijn, who has been awarded funding from the UKRI Medical Research Council to investigate how the first blood stem cells formed in the embryo acquire their exceptional regenerative potential, with the aim of informing future stem cell therapies.

How body fat is stored across organs may reveal hidden health risks, study suggests

University of Oxford researchers have found that how fat accumulates in the body is just as important for identifying different health risks as a person’s overall weight.

Professor KJ Patel awarded Royal Society Buchanan Medal

Congratulations to Professor Patel, who has received the Buchanan Medal, which recognises distinguished contributions to the biomedical sciences.

New pump-priming awards support cross-cutting research across RDM

Five Radcliffe Department of Medicine research teams have secured pump-priming funding to support new collaborations and early-stage research aligned with RDM’s cross-cutting research themes.